Search International and National Patent Collections
|1. (WO2018220080) POLYPEPTIDES ANTAGONIZING WNT SIGNALING IN TUMOR CELLS|
|Applicants:||BOEHRINGER INGELHEIM INTERNATIONAL GMBH
|Title:||POLYPEPTIDES ANTAGONIZING WNT SIGNALING IN TUMOR CELLS|
The invention provides novel LRP5-binding polypeptides, and more specifically novel LRP5-binding immunoglobulin single variable domain constructs which can inhibit Wnt signaling pathways. The invention also relates to specific sequences of such polypeptides, methods of their production, and methods of using them, including methods of treatment of diseases such as cancer.